참고문헌
- De Clercq E. Antivirals: past, present and future. Biochem Pharmacol 2013; 85: 727-44. https://doi.org/10.1016/j.bcp.2012.12.011
- Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol 2010; 48 Suppl 1: S2-7. https://doi.org/10.1016/S1386-6532(10)70002-0
- Kinchington PR, Leger AJ, Guedon JM, Hendricks RL. Herpes simplex virus and varicella zoster virus, the house guests who never leave. Herpesviridae 2012; 3: 5. https://doi.org/10.1186/2042-4280-3-5
- Quinlivan M, Breuer J. Molecular studies of varicella zoster virus. Rev Med Virol 2006; 16: 225-50. https://doi.org/10.1002/rmv.502
- Temin HM, Baltimore D. RNA-directed DNA synthesis and RNA tumor viruses. Adv Virus Res 1972; 17: 129-86. https://doi.org/10.1016/S0065-3527(08)60749-6
- Quinlivan M, Breuer J. Molecular and therapeutic aspects of varicella-zoster virus infection. Expert Rev Mol Med 2005; 7: 1-24.
- Weigle KA, Grose C. Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation. J Infect Dis 1984; 149: 741-9. https://doi.org/10.1093/infdis/149.5.741
- Arvin AM, Koropchak CM, Wittek AE. Immunologic evidence of reinfection with varicella-zoster virus. J Infect Dis 1983; 148: 200-5. https://doi.org/10.1093/infdis/148.2.200
- Gershon AA, Steinberg SP, Gelb L. Clinical reinfection with varicella-zoster virus. J Infect Dis 1984; 149: 137-42. https://doi.org/10.1093/infdis/149.2.137
- Johnson JA, Bloch KC, Dang BN. Varicella reinfection in a seropositive physician following occupational exposure to localized zoster. Clin Infect Dis 2011; 52: 907-9. https://doi.org/10.1093/cid/cir033
- Thakur R, Kent JL, Dworkin RH. Herpes zoster and postherpetic neuralgia. In: Bonica's management of pain. 4th ed. Edited by Fishman S, Ballantyne J, Rathmell JP, Bonica JJ. Philadelphia (PA), Lippincott Williams & Wilkins. 2010, pp 338-57.
- Flatt A, Breuer J. Varicella vaccines. Br Med Bull 2012; 103: 115-27. https://doi.org/10.1093/bmb/lds019
- Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis 2008; 197 Suppl 2: S224-7. https://doi.org/10.1086/522162
- Goldman GS, King PG. Review of the United States universal varicella vaccination program: herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data. Vaccine 2013; 31: 1680-94. https://doi.org/10.1016/j.vaccine.2012.05.050
- Hambleton S, Steinberg SP, Larussa PS, Shapiro ED, Gershon AA. Risk of herpes zoster in adults immunized with varicella vaccine. J Infect Dis 2008; 197 Suppl 2: S196-9. https://doi.org/10.1086/522131
- Goldman GS. Universal varicella vaccination: efficacy trends and effect on herpes zoster. Int J Toxicol 2005; 24: 205-13. https://doi.org/10.1080/10915810591000659
- Goldman GS. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology. Vaccine 2005; 23: 3349-55. https://doi.org/10.1016/j.vaccine.2003.10.042
- Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-84. https://doi.org/10.1056/NEJMoa051016
- Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis 2012; 54: 922-8. https://doi.org/10.1093/cid/cir970
- Shapiro M, Kvern B, Watson P, Guenther L, McElhaney J, McGeer A. Update on herpes zoster vaccination: a family practitioner's guide. Can Fam Physician 2011; 57: 1127-31.
- Nahm FS, Kim SH, Kim HS, Shin JW, Yoo SH, Yoon MH, et al. Survey on the treatment of postherpetic neuralgia in Korea; multicenter study of 1,414 patients. Korean J Pain 2013; 26: 21-6. https://doi.org/10.3344/kjp.2013.26.1.21
- Gagliardi AM, Gomes Silva BN, Torloni MR, Soares BG. Vaccines for preventing herpes zoster in older adults. Cochrane Database Syst Rev 2012; 10: CD008858.
피인용 문헌
- Medications in Treatment of Postherpetic Neuralgia vol.27, pp.1, 2014, https://doi.org/10.3344/kjp.2014.27.1.1
- Risk Factor and Prevention of Postherpetic Neuralgia vol.28, pp.3, 2015, https://doi.org/10.3344/kjp.2015.28.3.167
- Earlier treatment improves the chances of complete relief from postherpetic neuralgia vol.30, pp.3, 2017, https://doi.org/10.3344/kjp.2017.30.3.214
- The positive duration of varicella zoster immunoglobulin M antibody test in herpes zoster vol.95, pp.33, 2016, https://doi.org/10.1097/MD.0000000000004616
- Herpes zoster ophthalmicus associated with abducens palsy vol.5, pp.2, 2013, https://doi.org/10.4103/0976-3147.131673
- Chickenpox: An update vol.49, pp.1, 2013, https://doi.org/10.1016/j.medmal.2018.04.395
- Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia vol.33, pp.3, 2013, https://doi.org/10.3344/kjp.2020.33.3.201
- Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines vol.8, pp.4, 2020, https://doi.org/10.3390/vaccines8040566